← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 20, 2019Last known activity
Sep 12, 2025
Timeline
2010s
- Jan 1, 2017
ScandiBio Therapeutics AB— Founded
Drugs by trial phase (7 distinct, 4 trials)
Phase 3 (7 own, 0 via acquisition)
Indications
Recent trials (4)
- NCT07062198Lead sponsorPhase 3Sep 12, 2025
- NCT04573153Lead sponsorPhase 2/Phase 3Sep 21, 2020
- NCT04044131CollaboratorPhase 2Sep 1, 2019
- NCT04330326Lead sponsorPhase 2Jul 20, 2019
Details
- Founded
- Stockholm, SE Jan 1, 2017
- Last known activity
- Sep 12, 2025